Viatris Inc. (VTRS) News Headlines

▮ More

Date

Headline

5/22/2023 7:48:52 AM Viatris Says Robert Coury To Transition To Chairman Emeritus And Senior Strategic Advisor To Board At End Of Year

5/22/2023 6:36:19 AM Viatris Appoints Leo Groothuis To Board

5/8/2023 8:00:10 AM Viatris Q1 23 Earnings Conference Call At 8:30 AM ET

5/8/2023 7:32:49 AM Viatris Reaffirms FY23 Revenue Outlook, Declares Dividend - Update

5/8/2023 7:08:31 AM Viatris Inc. Q1 Income Falls

5/8/2023 7:04:26 AM Viatris Inc. (VTRS) Declares Quarterly Dividend of $ 0.12, Record Date 5/24/2023

5/8/2023 7:01:00 AM Viatris Q1 Adj. Net Earnings $932.9 Mln Vs. $1.125 Bln Last Year

4/24/2023 7:03:19 AM Viatris And Mapi Pharma To Highlight Latest Results Of Multiple Sclerosis Research At AAN 75th Annual Meeting

2/27/2023 7:59:34 AM Viatris Names Scott Smith CEO, Succeeding Michael Goettler, With Effect From April 1

2/27/2023 7:46:46 AM Viatris Appoints Scott Smith As CEO Effective April 1, 2023

2/27/2023 6:30:10 AM Viatris Q4 22 Earnings Conference Call At 8:30 AM ET

2/27/2023 6:29:12 AM Viatris Sees Weak Revenues, Adj. EBITDA In FY23 - Update

2/27/2023 6:05:10 AM Viatris Inc. Q4 Earnings Summary

2/27/2023 6:02:25 AM Viatris Q4 EPS $0.83 Vs Loss $0.22 Last Year

1/11/2023 3:00:03 PM Viatris To Present At J.P. Morgan Healthcare Conference; Webcast At 6:00 PM ET

1/3/2023 9:02:37 AM Viatris Closes Acquisitions Of Oyster Point Pharma And Famy Life Sciences

12/29/2022 4:06:24 PM Viatris Appoints Scott Smith And Elisha Finney To Board Of Directors

12/13/2022 3:23:16 AM Calliditas To Work With Viatris To Bring Nefecon To Japanese Patients

12/13/2022 3:04:01 AM Shield Therapeutics To Work With Viatris To Bring Accrufer In The U.S.

11/29/2022 8:02:19 AM Viatris Closes Biosimilars Transaction With Biocon Biologics